Fremont, Calif. and Las Vegas, Nev. – Shockwave Medical, a pioneer in the treatment of peripheral and coronary vascular disease, today announced positive clinical results from DISRUPT PAD, a ...
Another year, another multibillion-dollar cardiovascular acquisition for Johnson & Johnson MedTech. The company has inked a $13.1 billion deal to bring Shockwave Medical into the fold. J&J MedTech ...
Please provide your email address to receive an email when new articles are posted on . In the interim results of the observational DISRUPT PAD III study, intravascular lithotripsy was safe and ...
Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little ...
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
Pq Bypass Inc. received breakthrough device designation from the FDA for its Detour system, the first to permit fully percutaneous femoropopliteal bypass to treat extremely long, complex blockages in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback